ACTRN12622000220763招募中未知
eDIS-ICU - An international validation study to assess accuracy of a new screening tool for delirium in the intensive care unit
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Anticipated ICU length of stay of >24 hours from time of enrolment.
- •Greater than or equal to 18 years.
- •Able to communicate ‘Yes’ and ‘No’ consistently (verbal or non-verbal).
- •Informed consent obtained by participant / their legal representative.
排除标准
- •Pre-existing severe cognitive impairment preventing them from comprehending / answering assessment questions (as determined by the treating clinical team in consultation with the research team).
- •Insufficiently fluent in the language in use at the participating hospital to complete consent processes and/or follow instructions.
- •Patients with visual / hearing impairment preventing them from hearing verbal assessment instructions or visualising the app screen.
研究者
相似试验
尚未招募
不适用
eDIS-ICU: An international validation study to improve accuracy of screening for delirium in the ICU - A sub-analysis using ICDSC data from two institutions in JapadeliriumJPRN-UMIN000047064KAWASAKI MEDICAL SCHOOL HOSPITAL Department of Nursing220
招募中
3 期
Recombinant factor VIIa for hyperacute intracerebral hemorrhageSpontaneous intracerebral hemorrhageJPRN-jRCTs051200076Toyoda Kazunori400
已完成
不适用
International multicenter trial on diagnostic power of endocytoscopy for colorectal polyps: internet-based study comparing between the automated diagnostic system and endoscopistscolorectal polypsJPRN-UMIN000018185Digestive Disease Center, Showa University Northern Yokohama Hospital200
进行中（未招募）
不适用
International clinical study to investigate the efficacy and safety of Wiloctin in patients with inherited von willebrand disease (vWD)EUCTR2006-002857-54-DEOctapharma AG50
进行中（未招募）
1 期
An International Multi-center Phase 2 Study to Evaluate the Efficacy and Safety of Melphalan/HDS Treatment in Patients with Unresectable Hepatocellular Carcinoma or Intra hepatic Cholangiocarcinoma.unresectable hepatocellular carcinoma (HCC) confined to the liver and Intra hepatic Cholangiocarcinoma confined to the liver.MedDRA version: 18.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableSystem Organ Class: 100000004864MedDRA version: 18.1Level: LLTClassification code 10073077Term: Intrahepatic cholangiocarcinomaSystem Organ Class: 100000004864EUCTR2014-001585-98-DEDelcath Systems, Inc42